| 【Company Research】CSPC Pharmaceutical (1093 HK) –1H21 results beat; accelerating BD pace |
| 【Fixed Income Research】REDSUN - Looking for opportunities in the kinked credit curve |
| 【Company Research】Innovent Biologics (1801 HK) – Building world-leading innovation platform |
| 【Company Research】China Life (2628 HK) – Focus on agency upgrade |
| 【Fixed Income Research】KAISAG - Upside surprises |
| 【Fixed Income Research】EHouse - Profit Warning |
| 【Fixed Income Research】GZRFPR - More remedies needed |
| 【Company Research】Jiumaojiu (9922 HK) – Slightly more cautious after a bumpy Jul-Aug |
| 【Fixed Income Research】ZHLGHD - 1H21 Result in line with expectation |
| 【Company Research】Xiaomi (1810 HK) – 2Q21 beat on strong ads and margin; Maintain BUY |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
